Paid Clinical Trials in Edgewood, KY
As of July 2026, 51 paid clinical trials are recruiting in Edgewood, Kentucky. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Edgewood offers studies at sites including St. Elizabeth Healthcare for conditions such as Chronic Lymphocytic Leukemia, Heart Failure, Advanced Melanoma, Atrial Fibrillation. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Edgewood
Trials by drug in Edgewood
Filter results
Newly added in Edgewood
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast Cancer
Kentucky - Quality Improvement Implementation Lung Cancer Screening (QUILS™) Implementation
46 clinical trials
A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)
A Study of Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Non-small Cell Lung Cancer (V940-002)
A Study of Zilovertamab Vedotin (MK-2140) in Combination With Standard of Care in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (rrDLBCL) (MK-2140-003)
ELEVATE High-Risk PCI Pivotal Study
A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%
Prevail Global Study
IMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL-301)
Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)
EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)
AN INTERNATIONAL, OBSERVATIONAL, BLINDED STUDY TO ASSESS THE PERFORMANCE OF THE CORDIO HEARO SYSTEM
A Study of VARIPULSE Catheter in Participants With Persistent Atrial Fibrillation Undergoing Pulmonary Vein and Superior Vena Cava Isolation
A Clinical Study of Gocatamig (MK-6070) and Infinatamab Deruxtecan (MK-2400) in People With Small Cell Lung Cancer (MK-6070-003)
A Study to See if Giving Fianlimab and Cemiplimab Together is Better Than Cemiplimab Alone at Treating Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
A Study Evaluating the Efficacy and Safety of Pirtobrutinib in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Study to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NET
Study of PF-07248144 in Advanced or Metastatic Solid Tumors
A Phase 1 Study of LNCB74 in Advanced Solid Tumors
Cleaner Long-tErm Assessment Registry - Venous Insights and Efficacy With eXtended Tracking
Study to Evaluate IMGS-001 Treatment in Patients With Relapsed or Refractory Advanced Solid Tumors
A Study to Assess Adverse Events and Change in Disease Activity in Participants With Platinum-Resistant Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha Expression Treated With Intravenously (IV) Infused Mirvetuximab Soravtansine
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
Target Trial Emulation for Pharmacologic Treatment of Neonatal Opioid Withdrawal Syndrome
Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma
Top Research Study Locations in Edgewood
Researchers run research studies in Edgewood, KY at 18 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| St. Elizabeth Healthcare | Heart Failure, Lung Cancer Screening, Acute Myocardial Infarction | 13 |
| Saint Elizabeth Medical Center Edgewood | Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Chronic Lymphocytic Leukemia | 8 |
| Saint Elizabeth Healthcare Edgewood | Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Adenocarcinoma of the Colon | 4 |
| Saint Elizabeth Healthcare | Coronary Artery Disease, Tachyarrhythmia, Chronic Lymphocytic Leukemia | 4 |
| St Elizabeth Healthcare | Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET), Ovarian Cancer, Prostatic Neoplasms, Castration-Resistant | 3 |
| Saint Elizabeth Medical Center Edgewood-Cancer Care Center | Triple-Negative Breast Cancer, Breast Neoplasms, Non Small Cell Lung Cancer | 3 |
| St. Elizabeth Healthcare - Edgewood | Advanced Melanoma, Deep Vein Thrombosis (DVT), Thrombus in the Central and Peripheral Circulatory System, Including Saphenous Vein Grafts | 2 |
| Clinical Study Site | Metastatic Colorectal Cancer (CRC) | 1 |
| Saint Elizabeth Medical Center | Atrial Fibrillation | 1 |
| Saint Elizabeth Medical Center, Inc. DBA St. Elizabeth Health Care | Metastatic Pancreatic Adenocarcinoma, Metastatic Pancreatic Cancer, Pancreatic Cancer | 1 |
| St Elizabeth Health Care - CRI | Diabetes Mellitus, Type 2, Metabolic Syndrome, PreDiabetes | 1 |
| St Elizabeth Healthcare (St Elizabeth Medical | Advanced Melanoma | 1 |
| St Elizabeth Healthcare (St Elizabeth Medical Center) | Advanced Melanoma | 1 |
| St. Elizabeth - Edgewood | Lumbar Spinal Stenosis | 1 |
| St. Elizabeth Edgewood Hospital | Breast Cancer | 1 |
| St. Elizabeth Health | Atrial Fibrillation, Stroke | 1 |
| St. Elizabeth Medical Center | Solid Cancer | 1 |
| St. Elizabeth Medical Center - Edgewood | Advanced High-Grade Epithelial Ovarian Cancer, Fallopian Tube Cancers, Primary Peritoneal Cancer | 1 |
Active & Upcoming Studies in Edgewood (2026)
Recruiting trials in Edgewood grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (30 active studies)
- A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast Cancer · Phase 3 · AstraZeneca
- A Study to See if Giving Fianlimab and Cemiplimab Together is Better Than Cemiplimab Alone at Treating Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma · Phase 2 · Regeneron Pharmaceuticals
Cardiovascular (9 active studies)
- Computerized Decision Support to Prevent Stroke in Atrial Fibrillation · Brigham and Women's Hospital
- A Study of VARIPULSE Catheter in Participants With Persistent Atrial Fibrillation Undergoing Pulmonary Vein and Superior Vena Cava Isolation · Biosense Webster, Inc.
Diabetes & metabolic (2 active studies)
- Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D) · Phase 2 · Sparrow Pharmaceuticals
- A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events · Cleerly, Inc.
Neurology & pain (1 active study)
- Computerized Decision Support to Prevent Stroke in Atrial Fibrillation · Brigham and Women's Hospital
Pediatric (1 active study)
- Target Trial Emulation for Pharmacologic Treatment of Neonatal Opioid Withdrawal Syndrome · HELP for NOWS Consortium
Common conditions studied in Edgewood
- Chronic Lymphocytic Leukemia (3 active studies)
- Heart Failure (3 active studies)
- Advanced Melanoma (2 active studies)
- Atrial Fibrillation (2 active studies)
- Breast Cancer (2 active studies)
- Breast Neoplasms (2 active studies)
Leading research sponsors in Edgewood
- Merck Sharp & Dohme LLC
- Medtronic
- Alliance for Clinical Trials in Oncology
- Astellas Pharma Global Development, Inc.
- Immunocore Ltd
Frequently asked questions
How many paid clinical trials are currently recruiting in Edgewood?
There are approximately 51 recruiting clinical trials in Edgewood, Kentucky listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Edgewood pay participants?
Most recruiting trials in Edgewood compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Edgewood?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Edgewood?
The most common conditions under active study in Edgewood include Chronic Lymphocytic Leukemia (3), Heart Failure (3), Advanced Melanoma (2), Atrial Fibrillation (2), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Edgewood?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Edgewood on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Edgewood?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Edgewood?
Recruiting research sites in Edgewood include St. Elizabeth Healthcare, Saint Elizabeth Medical Center Edgewood, Saint Elizabeth Healthcare Edgewood, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Edgewood right now?
The largest active categories in Edgewood are Cancer & tumors (30), Cardiovascular (9), Diabetes & metabolic (2). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.